Cargando…

Zinc enhances temozolomide cytotoxicity in glioblastoma multiforme model systems

Temozolomide (TMZ) is an alkylating agent that has become the mainstay treatment of the most malignant brain cancer, glioblastoma multiforme (GBM). Unfortunately only a limited number of patients positively respond to it. It has been shown that zinc metal reestablishes chemosensitivity but this effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toren, Amos, Pismenyuk, Tatyana, Yalon, Michal, Freedman, Shani, Simon, Amos J., Fisher, Tamar, Moshe, Itai, Reichardt, Juergen K.V., Constantini, Shlomi, Mardor, Yael, Last, David, Guez, David, Daniels, Dianne, Assoulin, Moria, Mehrian-Shai, Ruty
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342707/ https://www.ncbi.nlm.nih.gov/pubmed/27556862 http://dx.doi.org/10.18632/oncotarget.11382

Ejemplares similares

High metallothionein predicts poor survival in glioblastoma multiforme
por: Mehrian-Shai, Ruty, et al.
Publicado: (2015)

HGG-04. ZINC ENHANCES TEMOZOLOMIDE CYTOTOXICITY IN PEDIATRIC GLIOBLASTOMA MULTIFORME MODEL SYSTEM
por: Toren, Amos, et al.
Publicado: (2020)

Identification of genomic aberrations in hemangioblastoma by droplet digital PCR and SNP microarray highlights novel candidate genes and pathways for pathogenesis
por: Mehrian-Shai, Ruty, et al.
Publicado: (2016)

Elevated NLR May Be a Feature of Pediatric Brain Cancer Patients
por: Yalon, Michal, et al.
Publicado: (2019)

MBRS-04. MEDULLOBLASTOMA DETECTION BY BLOOD TEST
por: Yalon, Michal, et al.
Publicado: (2020)

Novel age-dependent targets in vestibular schwannomas
por: Toren, Amos, et al.
Publicado: (2014)

Genomics is changing personal healthcare and medicine: the dawn of iPH (individualized preventive healthcare)
por: Mehrian-Shai, Ruty, et al.
Publicado: (2015)

A rational approach to COVID-19
por: Mehrian-Shai, Ruty
Publicado: (2020)

Genomics of COVID-19: molecular mechanisms going from susceptibility to severity of the disease
por: Mehrian-Shai, Ruty, et al.
Publicado: (2020)

MutT homolog 1 counteracts the effect of anti-neoplastic treatments in adult and pediatric glioblastoma cells
por: Versano, Ziv, et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

COVID-19 2022 update: transition of the pandemic to the endemic phase
por: Biancolella, Michela, et al.
Publicado: (2022)

MRI Study on Reversible and Irreversible Electroporation Induced Blood Brain Barrier Disruption
por: Hjouj, Mohammad, et al.
Publicado: (2012)

The Effect of Blood Flow on Magnetic Resonance Imaging of Non Thermal Irreversible Electroporation
por: Hjouj, Mohammad, et al.
Publicado: (2013)

A statistical model describing combined irreversible electroporation and electroporation-induced blood-brain barrier disruption
por: Sharabi, Shirley, et al.
Publicado: (2016)

COVID-19 update: the first 6 months of the pandemic
por: Novelli, Giuseppe, et al.
Publicado: (2020)

The application of point source electroporation and chemotherapy for the treatment of glioma: a randomized controlled rat study
por: Sharabi, Shirley, et al.
Publicado: (2020)

COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy
por: Novelli, Giuseppe, et al.
Publicado: (2021)

Pediatric glioblastoma cells are sensitive to drugs that inhibit eIF2α dephosphorylation and its phosphomimetic S51D variant
por: Eytan, Karin, et al.
Publicado: (2022)

Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenografts
por: Nishri, Yossi, et al.
Publicado: (2022)

Effectiveness of temozolomide for primary glioblastoma multiforme in routine clinical practice
por: van Genugten, J. A. B., et al.
Publicado: (2009)

Suppressing TRAP1 sensitizes glioblastoma multiforme cells to temozolomide
por: Wang, Nan, et al.
Publicado: (2021)

Interfering with mitochondrial dynamics sensitizes glioblastoma multiforme to temozolomide chemotherapy
por: Wang, Nan, et al.
Publicado: (2021)

Improved Outcomes with Intensity Modulated Radiation Therapy Combined with Temozolomide for Newly Diagnosed Glioblastoma Multiforme
por: Aherne, Noel J., et al.
Publicado: (2014)

Convection-enhanced delivery of methotrexate-loaded maghemite nanoparticles
por: Corem-Salkmon, Enav, et al.
Publicado: (2011)

Synthesis and preliminary biological evaluation of gabactyzine, a benactyzine-GABA mutual prodrug, as an organophosphate antidote
por: Weitman, Michal, et al.
Publicado: (2022)

Patterns of recurrence and outcomes of glioblastoma multiforme treated with chemoradiation and adjuvant temozolomide
por: Faustino, Alexandre Ciuffi, et al.
Publicado: (2020)

MRI-based diagnosis and treatment of pediatric brain tumors: is tissue sample always needed?
por: Soleman, Jehuda, et al.
Publicado: (2021)

An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?
por: Teraiya, Milan, et al.
Publicado: (2023)

Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide
por: Gebhardt, Brian J, et al.
Publicado: (2014)

Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme
por: Shields, Lisa BE, et al.
Publicado: (2013)

Preparation of Temozolomide-Loaded Nanoparticles for Glioblastoma Multiforme Targeting—Ideal Versus Reality
por: Lee, Chooi Yeng, et al.
Publicado: (2016)

Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models
por: Valtorta, Silvia, et al.
Publicado: (2017)

Delayed Contrast Extravasation MRI for Depicting Tumor and Non-Tumoral Tissues in Primary and Metastatic Brain Tumors
por: Zach, Leor, et al.
Publicado: (2012)

Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations
por: Yalon, Michal, et al.
Publicado: (2016)

Correction: Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations
por: Yalon, Michal, et al.
Publicado: (2016)

Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
por: Heynckes, Sabrina, et al.
Publicado: (2019)

Accelerated Hypofractionated Radiotherapy in the Era of Concurrent Temozolomide Chemotherapy in Elderly Patients with Glioblastoma Multiforme
por: Greer, Liana, et al.
Publicado: (2017)

Transient blood–brain barrier disruption is induced by low pulsed electrical fields in vitro: an analysis of permeability and trans-endothelial electric resistivity
por: Sharabi, Shirley, et al.
Publicado: (2019)

COVID-19 annual update: a narrative review
por: Biancolella, Michela, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tpsngeo1cce089fd81f60juv50